Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

Loughborough University Institutional Repository

Please use this identifier to cite or link to this item: https://dspace.lboro.ac.uk/2134/24806

Title: iGEMS: an integrated model for identification of alternative exon usage events
Authors: Sood, Sanjana
Szkop, Krzysztof J.
Nakhuda, Asif
Gallagher, Iain J.
Murie, Carl
Brogan, Robert J.
Kaprio, Jaakko
Kainulainen, Heikki
Atherton, Philip J.
Kujala, Urho M.
Gustafsson, Thomas
Larsson, Ola
Timmons, James A.
Issue Date: 2016
Publisher: Oxford University Press on behalf of Nucleic Acids Research. © The Author(s)
Citation: SOOD, S. ... et al, 2016. iGEMS: an integrated model for identification of alternative exon usage events. Nucleic Acids Research, 44 (11), pp. e109-e109.
Abstract: DNA microarrays and RNAseq are complementary methods for studying RNA molecules. Current computational methods to determine alternative exon usage (AEU) using such data require impractical visual inspection and still yield high false-positive rates. Integrated Gene and Exon Model of Splicing (iGEMS) adapts a gene-level residuals model with a gene size adjusted false discovery rate and exon-level analysis to circumvent these limitations. iGEMS was applied to two new DNA microarray datasets, including the high coverage Human Transcriptome Arrays 2.0 and performance was validated using RT-qPCR. First, AEU was studied in adipocytes treated with (n = 9) or without (n = 8) the anti-diabetes drug, rosiglitazone. iGEMS identified 555 genes with AEU, and robust verification by RT-qPCR (∼90%). Second, in a three-way human tissue comparison (muscle, adipose and blood, n = 41) iGEMS identified 4421 genes with at least one AEU event, with excellent RT-qPCR verification (95%, n = 22). Importantly, iGEMS identified a variety of AEU events, including 3′UTR extension, as well as exon inclusion/exclusion impacting on protein kinase and extracellular matrix domains. In conclusion, iGEMS is a robust method for identification of AEU while the variety of exon usage between human tissues is 5–10 times more prevalent than reported by the Genotype-Tissue Expression consortium using RNA sequencing.
Description: This is an Open Access Article. It is published by Oxford University Press under the Creative Commons Attribution 4.0 Licence (CC BY). Full details of this licence are available at: http://creativecommons.org/licenses/by/4.0/
Sponsor: Biotechnology and Biological Sciences Research Council, UK [BB/F021259/1 to J.T., in part]; Medical Research Council [G1100015 to J.T., in part]; FP7 EU project [277936 Metapredict to J.T., in part]; Swedish Research Council (to T.G.); Karolinska Institutet Foundation (to T.G.); Marianne Wallenberg Foundation (to T.G.); Swedish Research Council (to O.L.), Wallenberg Academy Fellow Program (to O.L.); Swedish Cancer Society (to O.L.). Funding for open access charge: Medical Research Council, UK.
Version: Published
DOI: 10.1093/nar/gkw263
URI: https://dspace.lboro.ac.uk/2134/24806
Publisher Link: http://dx.doi.org/10.1093/nar/gkw263
ISSN: 0305-1048
Appears in Collections:Published Articles (Sport, Exercise and Health Sciences)

Files associated with this item:

File Description SizeFormat
gkw263-2.pdfPublished version3.73 MBAdobe PDFView/Open

 

SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.